Market Cap:
$ SEC Filings
| Filing | Filed On |
|---|---|
| 8-K | 15 Feb 2017 |
| SC 13G/A | 13 Feb 2017 |
| 8-K | 13 Feb 2017 |
| NABRIVA THERAPEUTICS AG - SCHEDULE 13GA (AMEND. #1) | 13 Feb 2017 |
| PHASE4 PARTNERS LTD SC 13GA 12-31-2016 (NABRIVA THERAPEUTICS AG) | 10 Feb 2017 |
| 4 | 09 Feb 2017 |
| SEC SCHEDULE 13G | 09 Feb 2017 |
| 4 | 09 Feb 2017 |
| 4 | 09 Feb 2017 |
| 4 | 09 Feb 2017 |
| SC 13G/A | 08 Feb 2017 |
| 8-K | 09 Jan 2017 |
| 3 | 03 Jan 2017 |
| 3 | 30 Dec 2016 |
| 3 | 30 Dec 2016 |
| 3 | 30 Dec 2016 |
| 3 | 30 Dec 2016 |
| 3 | 30 Dec 2016 |
| 3 | 30 Dec 2016 |
| 3 | 30 Dec 2016 |
